Aterian, Inc. (NASDAQ:ATER – Get Free Report) CRO Phillip Lepper sold 7,721 shares of Aterian stock in a transaction on Wednesday, September 11th. The stock was sold at an average price of $3.06, for a total value of $23,626.26. Following the completion of the sale, the executive now directly owns 179,645 shares of the company’s stock, valued at approximately $549,713.70. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Aterian Trading Down 3.4 %
ATER opened at $3.25 on Friday. Aterian, Inc. has a 12-month low of $1.90 and a 12-month high of $6.54. The company has a market cap of $27.92 million, a price-to-earnings ratio of -0.39 and a beta of 2.04. The company’s 50 day moving average is $3.00 and its 200 day moving average is $2.98.
Aterian (NASDAQ:ATER – Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported ($0.52) EPS for the quarter, topping analysts’ consensus estimates of ($0.64) by $0.12. The company had revenue of $27.98 million for the quarter. Aterian had a negative return on equity of 64.24% and a negative net margin of 18.88%.
Institutional Inflows and Outflows
Aterian Company Profile
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.
See Also
- Five stocks we like better than Aterian
- Buy P&G Now, Before It Sets A New All-Time High
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- Stock Market Upgrades: What Are They?
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
- There Are Different Types of Stock To Invest In
- Kroger Stock is a Win-Win for Buy-and-Hold Investors
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.